Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Sensitisation data (human)

Currently viewing:

Administrative data

Endpoint:
sensitisation data (humans)
Type of information:
experimental study
Adequacy of study:
weight of evidence
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Case reports and Literature review.

Data source

Reference
Reference Type:
review article or handbook
Title:
Unnamed
Year:
2011

Materials and methods

Type of sensitisation studied:
respiratory
skin
Study type:
case report
Principles of method if other than guideline:
The case reports are supplemented by a systematic literature review of antibiotic occupational asthma.
GLP compliance:
not specified

Test material

Constituent 1
Chemical structure
Reference substance name:
Amoxicillin
EC Number:
248-003-8
EC Name:
Amoxicillin
Cas Number:
26787-78-0
Molecular formula:
C16H19N3O5S
IUPAC Name:
6-{[amino(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

Method

Type of population:
occupational
Route of administration:
other: inhalation, oral and dermal.
Details on study design:
TYPE OF TEST(S) USED: skin test (prick test); specific IgE; bronchial provocation test; oral challenge.

Results and discussion

Results of examinations:
RESULT OF CASE REPORT:
All patients developed a (predominantly) late asthmatic reaction accompanied by increased bronchial hyperresponsiveness as demonstrated by a fall in histamine PC20 concentration following challenge; these findings were repeatable on further testing but not seen after identical exposure to lactose powder alone. Following diagnosis, each patient avoided further exposure at work to the causative antibiotic with improvement or resolution of their symptoms. They were advised to avoid therapeutic use of amoxicillin.

Any other information on results incl. tables

Table 1. Cases of occupational asthma from antibiotics identified at Royal Brompton Hospital in the period 1995–2009.

 

Year of diagnosis

Workplace exposure

Allergic symptoms

Latency

Specific IgE

Bronchial provocation test

Agent

FEV1 response

Increase in histamine reactivity

1996

amoxicillin

wheeze, cough

27 years

penicilloyl G (+)

penicilloyl V (+)

amoxicillin

late

yes

2000

amoxicillin

wheeze, cough

27 years

amoxicilloyl (+)

amoxicillin

late

yes

 

 

Table 2. Published cases of occupational allergy to ampicillin 1953–2009

 

Reference

Year

Country

No.

Latency

Respiratoy symtoms

Skin test

Specific IgE

Bronchial provocation test

Oral challenge

1

1980

Spain

2

#1: 1 years

#2: 1 years

 

#1: rhinitis,

dyspnoea, wheeze

#2: cough, wheeze

not reported

negative

Not reported

not reported

2

1997

Belgium

1

6 months

cough, wheeze

not reported

not reported

amoxicillin:

(+ER*

LR*)

not reported

3

1998

Spain

1

27 years

cough, rhinitis,wheeze, dyspnea

amoxicillin (-)

ampicillin (-)

BP* (-)

BPP* (-)

MDM* (-)

amoxicillin(+)

ampicillin (-)

penicillin V (-)

amoxicillin:

(+ER*)

penicillin V (-)

amoxicillin (+LR*)

penicillin V (-)

*ER: early (asthmatic) response, *LR: late (asthmatic) response.

*MDM: minor determinant (penicillin) mix,*BP: benzylpenicillin

*(B)PP: (benzyl)penicilloyl polylysine

[1] E. Losada Cosmes, M. Hinojosa Macias, R. Acover Sanchez et al., “Asma por inhalaci ´on por penicilina ambiental,”Allergologia et Immunopathologia, vol. 7, supplement, pp. 288–293, 1980.

[2] O. Vandenplas, J. P. Delwiche, and M. De Jonghe, “Asthma to latex and amoxicillin,”Allergy, vol. 52, no. 11, pp. 1147–1149, 1997.

[3] I. Jimenez, E. Anton, I. Pic´ans, I. S´anchez, M. D. Qui˜nones, and J. Jerez, “Occupational asthma specific to amoxicillin,”Allergy, vol. 53, no. 1, pp. 104–105, 1998.

 

 

Applicant's summary and conclusion

Executive summary:

Amoxicillin has been reported as a cause of work-related asthma.

Two case reports were seen and diagnosed of amoxicillin. Each of the two cases was involved in the primary manufacture or formulation of antibiotics in the United Kingdom and had presented with new onset, work-related asthmatic symptoms. All patients developed a (predominantly) late asthmatic reaction accompanied by increased bronchial hyperresponsiveness.

Previous published case reports, including a total of 4 patients, are reviewed.

Two cases of dyspnoea after inhalation of amoxicillin were described in workers in the manufacture of antibiotics; in neither case was there objective evidence of immune sensitisation to amoxicillin. A factory worker in Belgium developed occupational asthma from amoxicillin and subsequently, while employed as a nurse, to latex.

Three employees had positive skin prick tests to penicillin G and/or amoxicillin.

The patient had allergic responses to both inhaled and oral amoxicillin, but not to oral penicillin V suggesting to the authors that the responsible antigenic determinant lay in the aminohydroxyphenyl side-chain of amoxicillin.